← Back to Search

Japanese group for Healthy Subjects (OTAKU Trial)

N/A
Waitlist Available
Led By Kim Madden, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within four weeks after the end of intervention
Awards & highlights

OTAKU Trial Summary

The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons

OTAKU Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four weeks (28 days) after the commencement of the trial
This trial's timeline: 3 weeks for screening, Varies for treatment, and four weeks (28 days) after the commencement of the trial for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of access to evidence summaries
Secondary outcome measures
Self-rated score in changing their practice based on the contents of the materials
Self-rated score of understanding the contents of the provided materials

OTAKU Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Japanese groupExperimental Treatment1 Intervention
Participants who will receive Japanese-translated version of evidence summaries
Group II: English groupActive Control1 Intervention
Participants who will receive English version of evidence summaries

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,597,723 Total Patients Enrolled
OrthoEvidenceUNKNOWN
Japanese Society for Fracture RepairUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~35 spots leftby Apr 2025